Table 2. Comorbidities, major clinical pathologies and final outcomes of various COVID-19 associated mucormycosis (CAM) patients
Cases No |
Type of CAM |
Comorbidities/ Pathologies/Complications |
Final outcomes |
References |
1. |
Pulmonary mucormycosis |
Long-standing diabetes mellitus, hypertension, and ischemic cardiomyopathy, end-stage renal disease |
Recovered |
[86] |
2 |
Disseminated mucormycosis |
Obesity and hypothyroidism, multiple sub-segmental pulmonary emboli, pericarditis, pericardial effusion, steatohepatitis |
Died |
[92] |
3 |
Mucormycosis |
Hypertension, asthma, mild tachycardia, tachypnea, moderate bilateral maxillary sinus mucosal and ethmoid sinus mucosal thickening, mucosal opacification |
Died |
[93] |
4 |
Rhino-Orbital mucormycosis |
Diabetes mellitus, multiple patchy ground-glass opacities in lungs, bilateral lid edema, soft tissue swelling in the right preseptal, malar, premaxillary, and retrobulbar regions |
Died |
[94] |
5 |
Gastrointestinal mucormycosis |
Arterial hypertension, giant gastric ulcers and deep hemorrhages, |
Died |
[95] |
6 |
Pulmonary mucormycosis |
Tension pneumothorax with bronchopleural fistula, necrotic empyema in lungs |
Died |
[96] |
7 |
Rhino-Orbital mucormycosis |
Diabetes, asthma, hypertension, hyperlipidemia, asymmetric retrobulbar fat stranding and extensive opacification of right maxillary, ethmoid, and frontal sinuses, conjunctival chemosis, erythema and edema of the eyelids, kidney injury |
Died |
[84] |
8 |
Pulmonary mucormycosis |
Arterial hypertension, opacification of the left maxillary sinus and thickening with sclerosis of sinus walls |
Died |
[85] |
9 |
Sino-orbital mucormycosis |
Malaise, proptosis, chemosis, periorbital cellulitis |
Recovered |
[97] |
10 |
Paranasal mucormycosis |
Diabetes, opacification of the left ethmoid, maxillary and frontal sinus, thickening of the left optic nerve |
Recovered |
[98] |
11 |
Mucormycosis |
Diabetes mellitus, hyperglycaemia, thickening and perineural enhancement of the left optic nerve |
Recovered |
[99] |